Summary
- Current Price
- As of today, SNY price is $43.72, down -0.14% on
- Current Price All-Time High
- SNY price is currently -27.28% below its historical high of $60.12 set on
- Market Cap
- SNY current market cap is $105B, down -19.13% year-over-year
- PE Ratio
- SNY current PE ratio is 20.77
- Revenue
- SNY current annual revenue is $49.24B, up +10.80% year-over-year
- Next Earnings
- The next earnings release for SNY is on
Profile
| Metric | Value |
|---|---|
| Full Name | Sanofi |
| Ticker | NASDAQ: SNY |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | General Drug Manufacturers |
| Country | France |
| IPO | |
| Indexes | Not included |
| Website | sanofi.com |
| Employees | 82,878 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $43.72 | |
| Price, 1D Change | -0.14% | |
| Market Cap | $105B | |
| TTM Dividend Yield | 5.54% | |
| PE Ratio | 20.77 | |
| Beta | 0.31 | |
| Revenue | $49.24B | |
| Revenue, 1Y Change | +10.80% | |
| EPS | $2.40 | |
| EPS, 1Y Change | +0.07% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $2.42 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 5:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | $2.40 | |
| EPS Estimate | - | N/A |
| EPS Est. Change | - | N/A |
| Revenue | $49.24B | |
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $43.72 | |
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $2.32 | - | |
| - | $2.39 | - | |
| - | $2.40 | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $40.88B | - | |
| - | $44.44B | - | |
| - | $49.24B | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | -10.85% | |
| Price, 3Y | -17.94% | |
| Market Cap, 1Y | -19.13% | |
| Market Cap, 3Y | -25.56% | |
| Revenue, 1Y | +10.80% | |
| Revenue, 3Y | +8.95% | |
| EPS, 1Y | +0.07% | |
| EPS, 3Y | -31.55% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $43.72 | |
| SMA 200 | $46.17 | |
| SMA 50 | $43.40 | |
| EMA 200 | $45.67 | |
| EMA 50 | $43.64 | |
| MACD | $0.02 | |
| Beta | 0.31 | |
| ATR | $0.82 | |
| 14-Day RSI | 52.12 | |
| 10-Day Volatility | 8.12% |
Dividends
| Metric | Value | Date |
|---|---|---|
| Last Paid | $2.42 | |
| Upcoming | N/A | N/A |
| Dividend Yield | 5.02% | |
| Total Dividend | $2.20 | |
| Dividends Paid | $5.39B | |
| Payout Ratio | 95.88% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $49.24B | |
| EPS | $2.40 | |
| Gross Profit | $34.51B | |
| Gross Margin | 70.09% | |
| Operating Income | $16.08B | |
| Operating Margin | 32.67% | |
| Net Income | $5.62B | |
| Net Margin | 11.41% | |
| EBITDA | $19.29B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 0.28 | |
| Current Ratio | 1.09 | |
| Quick Ratio | 0.73 | |
| Interest Coverage | - | |
| Piotroski F-Score | - | |
| Altman Z-Score | 2.42 |
Valuations
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $83.83B | |
| Cash & Equivalents | $9.01B | |
| Total Assets | $148.93B | |
| Current Assets | $36.35B | |
| Total Liabilities | $64.71B | |
| Current Liabilities | $33.29B | |
| Total Debt | $23.88B | |
| Short Term Debt | $5.42B | |
| Accounts Payable | $26.93B |
Expenses
| Metric | Value | Date |
|---|---|---|
| Total Expenses | $43.66B | |
| Operating Expenses | $18.43B | |
| Cost Of Goods Sold | $16.89B | |
| SG&A | $10.77B | |
| D&A | $6.41B | |
| Interest Expense | $0.00 | |
| Income Tax | $1.18B |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| CFO | $12.13B | |
| CFI | -$2.76B | |
| CFF | -$9.26B | |
| Capex | $4.08B | |
| Free Cash Flow | $8.05B |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| UBS | → | |
| Barclays | → | |
| Guggenheim | → | |
| JP Morgan | → | |
| Morgan Stanley | → | |
| Deutsche Bank | → | |
| JP Morgan | → | |
| Goldman Sachs | ||
| Argus Research | → | |
| Morgan Stanley |
Analyst sentiment
Institutional ownership
Screeners with SNY
FAQ
- What is the ticker symbol for Sanofi?
- The ticker symbol for Sanofi is NASDAQ:SNY
- Does Sanofi pay dividends?
- Yes, Sanofi pays dividends. The last payment was $2.42, with an ex-dividend date on May 4, 2026
- What sector is Sanofi in?
- Sanofi is in the Healthcare sector
- What industry is Sanofi in?
- Sanofi is in the General Drug Manufacturers industry
- What country is Sanofi based in?
- Sanofi is headquartered in France
- When did Sanofi go public?
- Sanofi initial public offering (IPO) was on July 1, 2002
- Is Sanofi in the S&P 500?
- No, Sanofi is not included in the S&P 500 index
- Is Sanofi in the NASDAQ 100?
- No, Sanofi is not included in the NASDAQ 100 index
- Is Sanofi in the Dow Jones?
- No, Sanofi is not included in the Dow Jones index
- When was Sanofi last earnings report?
- Sanofi's most recent earnings report was on July 30, 2026
- When does Sanofi report earnings?
- The next expected earnings date for Sanofi is October 30, 2026
Data Sources & References
- SNY Official Website www.sanofi.com
- SNY Profile on Yahoo Finance finance.yahoo.com/quote/SNY
- SNY Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/sny